New Lipitor Lawsuit Says Drug Gave Woman Diabetes

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

Mary Kirkland and her husband Jasper L. Kirkland Jr. have filed a defective drug lawsuit against drug manufacturer Pfizer. Their joint suit alleges that Pfizer’s cholesterol drug Lipitor caused Mary to develop type-2 diabetes.

Mary Kirkland was prescribed Lipitor in April of 2004, and continued to take the drug up until April of 2012. During this time, the lawsuit contends that Kirkland took the drug as prescribed by her physicians in order to help lower her cholesterol levels in the hope of decreasing her chances of later developing cardiovascular disease.

In July of 2006, Kirkland was diagnosed with type-2 diabetes, this required her to adopt a regimen that includes monitoring her blood sugar levels. The Lipitor lawsuit states that Kirkland had no way of discovering that the drug could have caused her diabetes until recently. She said that she would have never used the drug had she been aware of the risk of diabetes.

The Kirklands’ lawsuit alleges that Pfizer, the manufacturer of Lipitor, were aware—or reasonably should have been aware—of the risk of developing diabetes from Lipitor. The text of the complaint states that by 1996 at the latest, data existed demonstrating a link between Lipitor and type-2 diabetes. The Lipitor lawsuit also cites scientific literature that indicated the same issue.

The Lipitor lawsuit further asserts that not only were the manufacturers aware of the risks associated with their drug, but that they actively tried to conceal the risk from patients like Kirkland. To support this assertion, the lawsuit cites the fact that when the U.S. Food and Drug Administration (FDA) demanded the makers of Lipitor add information about the risk of diabetes to the drug’s prescribing information, they included the phrase, “Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including Lipitor,” which makes no mention of the term “diabetes.”

The case is Mary L. Kirkland, et al. v. Pfizer Incorporated, Case No. 13-cv-02684, filed in the United States District Court for the Middle District of Pennsylvania, Scranton Division.

Free Help for Women who Took Lipitor & Developed Diabetes

If you’re a woman who took Lipitor, or you know a woman who took Lipitor, and later developed type-2 diabetes, you have legal options. Please visit the Lipitor Diabetes Class Action Lawsuit Investigation. There, you can submit your claim for a free legal review and if it qualifies for legal action, a seasoned Lipitor lawyer will contact you for a free, no-obligation consultation. You will be guided through the litigation process at no out-of-pocket expenses or hidden fees. The Lipitor attorneys working this investigation do not get paid until you do.